ArticlePLOS global public health2025
The treatment gap and the HIV care continuum for cisgender men who have sex with men in three South African cities: Findings from a biobehavioural survey, 2019.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Observational
- Predictors of unsuppressed viral load among MSM with HIV in South Africa.AIDS (London, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe HIV continuum of care for men who have sex with men (MSM) in South Africa remains inadequately characterised, hindering the tracking of progress towards ending the HIV epidemic. We estimated HIV prevalence and care continuum indicators for MSM in three South African cities. METHODS AND
findingsMSM were recruited via respondent-driven sampling (RDS) methods in Cape Town, Johannesburg, and Mahikeng. Eligibility criteria included age ≥ 18 years, assigned male sex at birth, recent oral or anal sex with a man, and living, working, or socialising in one of the selected cities within the past six months. Participants completed a survey, and dried blood spots were collected to test for HIV antibodies, antiretrovirals, and HIV viral load. RDS weights were used to estimate HIV prevalence and 95-95-95 care continuum indicators. From May to October 2019, 1,790 cisgender MSM were sampled. HIV prevalence was highest in Johannesburg (weighted prevalence = 40.7%, 95% confidence interval 34.4-47.3), followed by Cape Town (25.2%, 20.9-30.1) and Mahikeng (14.7%, 12.0-17.8). Among MSM living with HIV, awareness of status was 67.0% (56.8-75.8) in Cape Town, 67.8% (56.7-77.1) in Johannesburg, and 60.2% (49.9-69.8) in Mahikeng. ART coverage among those aware of their status was 65.1% (53.4-75.2) in Cape Town, 77.9% (67.2-85.8) in Johannesburg, and 72.5% (58.6-83.0) in Mahikeng. Viral suppression among those on ART was 79.3% (59.5-90.9) in Cape Town, 88.7% (77.8-94.6) in Johannesburg, and 90.7% (78.1-96.4) in Mahikeng.
conclusionsAchievements towards HIV care indicators were sub-optimal for MSM in three South African sites, revealing potential gaps in the reach and uptake of HIV testing and treatment services. Research identifying multi-level determinants of these gaps is needed to guide the development of contextually appropriate and effective interventions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.